Listen on the go
CORRECT!
Next question
touchRESPIRATORY touchRESPIRATORY

Start Learning

Touch Loading image
JOURNALS
Start Learning
Reflecting on 2024 and looking ahead to 2025: A message from Dr Xander Bertels, New Patient Advisory Board & Advocacy Manager, EUFOREA
touchIN CONVERSATION
Start Learning
Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment
CE/CME ACCREDITED
Image of human lungs in neural connections with neon background. Concept of innovation and medical technologies. Generated by artificial intelligence
JOURNALS
Start Learning
Study finds early BMI patterns shape long-term lung health
touchTALKS
Start Learning
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
CE/CME ACCREDITED
JOURNALS
Start Learning
Advancements in the Treatment of Paediatric Sleep-disordered Breathing Using Hypoglossal Nerve Stimulation
JOURNALS
Start Learning
Asthma Right Care: Aiming to improve asthma management globally
touchFOCUS
Start Learning
Current treatments and unmet needs in limited-stage small cell lung cancer
CE/CME ACCREDITED
JOURNALS
Start Learning
European Respiratory Society publish new statement on preschool wheezing disorders
touchIN CONVERSATION
Start Learning
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
CE/CME ACCREDITED
touchEXPERT OPINIONS
Start Learning
Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines
CE/CME ACCREDITED

to view Favourites, Keep Notes and Track CME Credits

Favourites
Foreword – touchREVIEWS in Respiratory & Pulmonary Diseases, Volume 9, Issue 1, 2024
View
WHO report highlights severe health risks from air pollution
View
New treatment for eosinophilic asthma and COPD exacerbations shows potential
View
Addressing the diagnosis and management of pet allergies in primary care and beyond
View
GINA 2024: Key Updates to optimise asthma care standards
View
The Impact of Nasal Anatomical Abnormalities on Respiratory Conditions: A Focused Literature Review
View
Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond
View
Dietetic intervention in malnourished patients with interstitial lung disease
View
Inflammation, disease progression and impact in COPD
View
Dupilumab gains first-in-world approval for treating COPD with elevated blood eosinophils
View
In Partnership with...
Useful Links:
About us Society Partners Press Releases Contact Us Permissions Terms & Conditions Privacy Policy Cookie Preferences
Connect With Us:

Other websites from Touch Medical Media:

touchONCOLOGY
touchOPHTHALMOLOGY
touchENDOCRINOLOGY
touchNEUROLOGY
touchCARDIO
touchRESPIRATORY
touchIMMUNOLOGY
touchINFECTIOUS DISEASES
touchHAEMATOLOGY
touchDERMATOLOGY

Copyright® 2025 Touch Medical Media. Touch Medical Media Group Holdings Limited, a private limited company registered in England and Wales at 3 Stockport Exchange | Stockport | Cheshire | SK1 3GG | UK with registered number 08197142.

touchRESPIRATORY is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.

Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup